Cargando…
Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-(18)F-Fluoroglutamine
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040374/ https://www.ncbi.nlm.nih.gov/pubmed/35493509 http://dx.doi.org/10.3389/fimmu.2022.902544 |
| _version_ | 1784694322910724096 |
|---|---|
| author | Palani, Senthil Miner, Maxwell W. G. Virta, Jenni Liljenbäck, Heidi Eskola, Olli Örd, Tiit Ravindran, Aarthi Kaikkonen, Minna U. Knuuti, Juhani Li, Xiang-Guo Saraste, Antti Roivainen, Anne |
| author_facet | Palani, Senthil Miner, Maxwell W. G. Virta, Jenni Liljenbäck, Heidi Eskola, Olli Örd, Tiit Ravindran, Aarthi Kaikkonen, Minna U. Knuuti, Juhani Li, Xiang-Guo Saraste, Antti Roivainen, Anne |
| author_sort | Palani, Senthil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9040374 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90403742022-04-27 Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-(18)F-Fluoroglutamine Palani, Senthil Miner, Maxwell W. G. Virta, Jenni Liljenbäck, Heidi Eskola, Olli Örd, Tiit Ravindran, Aarthi Kaikkonen, Minna U. Knuuti, Juhani Li, Xiang-Guo Saraste, Antti Roivainen, Anne Front Immunol Immunology Frontiers Media S.A. 2022-04-12 /pmc/articles/PMC9040374/ /pubmed/35493509 http://dx.doi.org/10.3389/fimmu.2022.902544 Text en Copyright © 2022 Palani, Miner, Virta, Liljenbäck, Eskola, Örd, Ravindran, Kaikkonen, Knuuti, Li, Saraste and Roivainen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Palani, Senthil Miner, Maxwell W. G. Virta, Jenni Liljenbäck, Heidi Eskola, Olli Örd, Tiit Ravindran, Aarthi Kaikkonen, Minna U. Knuuti, Juhani Li, Xiang-Guo Saraste, Antti Roivainen, Anne Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-(18)F-Fluoroglutamine |
| title | Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-(18)F-Fluoroglutamine |
| title_full | Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-(18)F-Fluoroglutamine |
| title_fullStr | Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-(18)F-Fluoroglutamine |
| title_full_unstemmed | Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-(18)F-Fluoroglutamine |
| title_short | Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2S,4R)-4-(18)F-Fluoroglutamine |
| title_sort | corrigendum: exploiting glutamine consumption in atherosclerotic lesions by positron emission tomography tracer (2s,4r)-4-(18)f-fluoroglutamine |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040374/ https://www.ncbi.nlm.nih.gov/pubmed/35493509 http://dx.doi.org/10.3389/fimmu.2022.902544 |
| work_keys_str_mv | AT palanisenthil corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT minermaxwellwg corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT virtajenni corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT liljenbackheidi corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT eskolaolli corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT ordtiit corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT ravindranaarthi corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT kaikkonenminnau corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT knuutijuhani corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT lixiangguo corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT sarasteantti corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine AT roivainenanne corrigendumexploitingglutamineconsumptioninatheroscleroticlesionsbypositronemissiontomographytracer2s4r418ffluoroglutamine |